These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6606107)

  • 21. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.
    Posavad CM; Newton JJ; Rosenthal KL
    J Virol; 1994 Jun; 68(6):4072-4. PubMed ID: 8189546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus.
    Kolaitis G; Doymaz M; Rouse BT
    Immunology; 1990 Sep; 71(1):101-6. PubMed ID: 2210799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2.
    McDermott MR; Goldsmith CH; Rosenthal KL; Brais LJ
    J Infect Dis; 1989 Mar; 159(3):460-6. PubMed ID: 2783720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of stable target cells for anti-herpes simplex virus cytotoxic T lymphocytes.
    Sonoda S; Hitsumoto Y; Utsumi S; Takami S; Oseto M; Minamishima Y
    Microbiol Immunol; 1981; 25(10):999-1010. PubMed ID: 6118814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of cytotoxic T lymphocyte activity after inoculation of herpes simplex virus into the anterior chamber of mice.
    Watanabe M; Sakata H; Tsumura K
    Ophthalmologica; 1994; 208(6):325-8. PubMed ID: 7845649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
    Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity.
    Bonneau RH; Jennings SR
    J Virol; 1989 Mar; 63(3):1480-4. PubMed ID: 2536848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytotoxic T lymphocyte activity after intravitreal inoculation of herpes simplex virus type I in mice].
    Tsumura K
    Nippon Ganka Gakkai Zasshi; 1993 Jul; 97(7):820-6. PubMed ID: 8352079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional cytotoxic T cells are associated with focal lesions in the brains of SJL mice with experimental herpes simplex encephalitis.
    Hudson SJ; Streilein JW
    J Immunol; 1994 Jun; 152(11):5540-7. PubMed ID: 8189071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress-induced modulation of the primary cellular immune response to herpes simplex virus infection is mediated by both adrenal-dependent and independent mechanisms.
    Bonneau RH; Sheridan JF; Feng N; Glaser R
    J Neuroimmunol; 1993 Feb; 42(2):167-76. PubMed ID: 8429102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice.
    Horohov DW; Moore RN; Rouse BT
    J Virol; 1985 Jun; 54(3):798-803. PubMed ID: 2987531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.
    Zhang X; Issagholian A; Berg EA; Fishman JB; Nesburn AB; BenMohamed L
    J Virol; 2005 Dec; 79(24):15289-301. PubMed ID: 16306600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus.
    Mueller SN; Jones CM; Smith CM; Heath WR; Carbone FR
    J Exp Med; 2002 Mar; 195(5):651-6. PubMed ID: 11877488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
    J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.